HEADER MEMBRANE PROTEIN 28-MAY-20 7C86 TITLE TIME-RESOLVED SERIAL FEMTOSECOND CRYSTALLOGRAPHY REVEALS EARLY TITLE 2 STRUCTURAL CHANGES IN CHANNELRHODOPSIN: DARK STATE STRUCTURE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SENSORY OPSIN A,CHANNELRHODOPSIN (CHR) CHIMERA BETWEEN CHR1 COMPND 3 & CHR2; COMPND 4 CHAIN: A; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CHLAMYDOMONAS REINHARDTII; SOURCE 3 ORGANISM_TAXID: 3055; SOURCE 4 GENE: CSOA; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: VACURO VIRUS; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PFASTBAC KEYWDS CHANNELRHODOPSIN, RHODOPSIN, MEMBRANE PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR K.ODA,T.NOMURA,T.NAKANE,K.YAMASHITA,K.INOUE,S.ITO,J.VIEROCK,K.HIRATA, AUTHOR 2 A.D.MATURANA,K.KATAYAMA,T.IKUTA,I.ISHIGAMI,T.IZUME,R.UMEDA,R.EGUMA, AUTHOR 3 S.OISHI,G.KASUYA,T.KATO,T.KUSAKIZAKO,W.SHIHOYA,H.SHIMADA, AUTHOR 4 T.TAKATSUJI,M.TAKEMOTO,R.TANIGUCHI,A.TOMITA,R.NAKAMURA,M.FUKUDA, AUTHOR 5 H.MIYAUCHI,Y.LEE,E.NANGO,R.TANAKA,T.TANAKA,M.SUGAHARA,T.KIMURA, AUTHOR 6 T.SHIMAMURA,T.FUJIWARA,Y.YAMANAKA,S.OWADA,Y.JOTI,K.TONO,R.ISHITANI, AUTHOR 7 S.HAYASHI,H.KANDORI,P.HEGEMANN,S.IWATA,M.KUBO,T.NISHIZAWA,O.NUREKI REVDAT 4 23-OCT-24 7C86 1 REMARK REVDAT 3 29-NOV-23 7C86 1 REMARK REVDAT 2 06-SEP-23 7C86 1 REMARK REVDAT 1 07-APR-21 7C86 0 JRNL AUTH K.ODA,T.NOMURA,T.NAKANE,K.YAMASHITA,K.INOUE,S.ITO,J.VIEROCK, JRNL AUTH 2 K.HIRATA,A.D.MATURANA,K.KATAYAMA,T.IKUTA,I.ISHIGAMI,T.IZUME, JRNL AUTH 3 R.UMEDA,R.EGUMA,S.OISHI,G.KASUYA,T.KATO,T.KUSAKIZAKO, JRNL AUTH 4 W.SHIHOYA,H.SHIMADA,T.TAKATSUJI,M.TAKEMOTO,R.TANIGUCHI, JRNL AUTH 5 A.TOMITA,R.NAKAMURA,M.FUKUDA,H.MIYAUCHI,Y.LEE,E.NANGO, JRNL AUTH 6 R.TANAKA,T.TANAKA,M.SUGAHARA,T.KIMURA,T.SHIMAMURA, JRNL AUTH 7 T.FUJIWARA,Y.YAMANAKA,S.OWADA,Y.JOTI,K.TONO,R.ISHITANI, JRNL AUTH 8 S.HAYASHI,H.KANDORI,P.HEGEMANN,S.IWATA,M.KUBO,T.NISHIZAWA, JRNL AUTH 9 O.NUREKI JRNL TITL TIME-RESOLVED SERIAL FEMTOSECOND CRYSTALLOGRAPHY REVEALS JRNL TITL 2 EARLY STRUCTURAL CHANGES IN CHANNELRHODOPSIN. JRNL REF ELIFE V. 10 2021 JRNL REFN ESSN 2050-084X JRNL PMID 33752801 JRNL DOI 10.7554/ELIFE.62389 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0266 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 17940 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.184 REMARK 3 R VALUE (WORKING SET) : 0.182 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 901 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1270 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.63 REMARK 3 BIN R VALUE (WORKING SET) : 0.2980 REMARK 3 BIN FREE R VALUE SET COUNT : 66 REMARK 3 BIN FREE R VALUE : 0.2850 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2317 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 174 REMARK 3 SOLVENT ATOMS : 38 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 67.07 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.58000 REMARK 3 B22 (A**2) : -5.49000 REMARK 3 B33 (A**2) : 3.90000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.242 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.204 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.150 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.450 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.963 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.943 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2545 ; 0.008 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 2439 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3426 ; 1.393 ; 1.648 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5598 ; 1.314 ; 1.573 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 293 ; 5.827 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 115 ;35.587 ;21.478 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 371 ;16.241 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 7 ;19.455 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 329 ; 0.069 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2779 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 585 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 7C86 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 29-MAY-20. REMARK 100 THE DEPOSITION ID IS D_1300017162. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-OCT-16 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : 6.9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : FREE ELECTRON LASER REMARK 200 BEAMLINE : BL3 REMARK 200 X-RAY GENERATOR MODEL : SACLA BEAMLINE BL3 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.77 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MPCCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTFEL 0.6.3 REMARK 200 DATA SCALING SOFTWARE : CRYSTFEL 0.6.3 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18961 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 47.350 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 561.2 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.6400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 6.24 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 48.78 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 1550. REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 19.46 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3UG9 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.07 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.62 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM MES, PH 6.9, 100 MM NA FORMATE, REMARK 280 AND 30% PEG500DME, LIPIDIC CUBIC PHASE, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 47.35000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 47.35000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 30.90000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 71.10000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 30.90000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 71.10000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 47.35000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 30.90000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 71.10000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 47.35000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 30.90000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 71.10000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8090 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 26920 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -52.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 47.35000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 ARG A 3 REMARK 465 ARG A 4 REMARK 465 PRO A 5 REMARK 465 TRP A 6 REMARK 465 LEU A 7 REMARK 465 LEU A 8 REMARK 465 ALA A 9 REMARK 465 LEU A 10 REMARK 465 ALA A 11 REMARK 465 LEU A 12 REMARK 465 ALA A 13 REMARK 465 VAL A 14 REMARK 465 ALA A 15 REMARK 465 LEU A 16 REMARK 465 ALA A 17 REMARK 465 ALA A 18 REMARK 465 GLY A 19 REMARK 465 SER A 20 REMARK 465 ALA A 21 REMARK 465 GLY A 22 REMARK 465 ALA A 23 REMARK 465 SER A 24 REMARK 465 THR A 25 REMARK 465 GLY A 26 REMARK 465 SER A 27 REMARK 465 ASP A 28 REMARK 465 ALA A 29 REMARK 465 THR A 30 REMARK 465 VAL A 31 REMARK 465 PRO A 32 REMARK 465 VAL A 33 REMARK 465 ALA A 34 REMARK 465 THR A 35 REMARK 465 GLN A 36 REMARK 465 ASP A 37 REMARK 465 GLY A 38 REMARK 465 PRO A 39 REMARK 465 ASP A 40 REMARK 465 TYR A 41 REMARK 465 VAL A 42 REMARK 465 PHE A 43 REMARK 465 HIS A 44 REMARK 465 ARG A 45 REMARK 465 ALA A 46 REMARK 465 HIS A 47 REMARK 465 GLU A 48 REMARK 465 GLN A 112 REMARK 465 THR A 113 REMARK 465 TRP A 114 REMARK 465 LYS A 115 REMARK 465 SER A 116 REMARK 465 THR A 117 REMARK 465 GLY A 329 REMARK 465 GLY A 330 REMARK 465 LEU A 353 REMARK 465 TYR A 354 REMARK 465 PHE A 355 REMARK 465 GLN A 356 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 49 CG CD NE CZ NH1 NH2 REMARK 470 MET A 50 CG SD CE REMARK 470 CYS A 118 SG REMARK 470 LYS A 186 CG CD CE NZ REMARK 470 LYS A 244 CG CD CE NZ REMARK 470 ASN A 327 CG OD1 ND2 REMARK 470 ILE A 328 CG1 CG2 CD1 REMARK 470 THR A 331 OG1 CG2 REMARK 470 GLU A 332 CG CD OE1 OE2 REMARK 470 GLU A 342 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 139 36.27 -142.85 REMARK 500 ALA A 345 28.25 -155.69 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 OLC A 403 REMARK 610 OLC A 404 REMARK 610 OLC A 405 REMARK 610 OLC A 406 REMARK 610 OLC A 407 REMARK 610 OLC A 408 REMARK 610 OLC A 409 REMARK 610 OLC A 410 DBREF 7C86 A 1 245 UNP Q8L435 Q8L435_CHLRE 1 245 DBREF 7C86 A 246 356 PDB 7C86 7C86 246 356 SEQRES 1 A 356 MET SER ARG ARG PRO TRP LEU LEU ALA LEU ALA LEU ALA SEQRES 2 A 356 VAL ALA LEU ALA ALA GLY SER ALA GLY ALA SER THR GLY SEQRES 3 A 356 SER ASP ALA THR VAL PRO VAL ALA THR GLN ASP GLY PRO SEQRES 4 A 356 ASP TYR VAL PHE HIS ARG ALA HIS GLU ARG MET LEU PHE SEQRES 5 A 356 GLN THR SER TYR THR LEU GLU ASN ASN GLY SER VAL ILE SEQRES 6 A 356 CYS ILE PRO ASN ASN GLY GLN CYS PHE CYS LEU ALA TRP SEQRES 7 A 356 LEU LYS SER ASN GLY THR ASN ALA GLU LYS LEU ALA ALA SEQRES 8 A 356 ASN ILE LEU GLN TRP ILE THR PHE ALA LEU SER ALA LEU SEQRES 9 A 356 CYS LEU MET PHE TYR GLY TYR GLN THR TRP LYS SER THR SEQRES 10 A 356 CYS GLY TRP GLU GLU ILE TYR VAL ALA THR ILE GLU MET SEQRES 11 A 356 ILE LYS PHE ILE ILE GLU TYR PHE HIS GLU PHE ASP GLU SEQRES 12 A 356 PRO ALA VAL ILE TYR SER SER ASN GLY ASN LYS THR VAL SEQRES 13 A 356 TRP LEU ARG TYR ALA GLU TRP LEU LEU THR CYS PRO VAL SEQRES 14 A 356 ILE LEU ILE HIS LEU SER ASN LEU THR GLY LEU ALA ASN SEQRES 15 A 356 ASP TYR ASN LYS ARG THR MET GLY LEU LEU VAL SER ASP SEQRES 16 A 356 ILE GLY THR ILE VAL TRP GLY THR THR ALA ALA LEU SER SEQRES 17 A 356 LYS GLY TYR VAL ARG VAL ILE PHE PHE LEU MET GLY LEU SEQRES 18 A 356 CYS TYR GLY ILE TYR THR PHE PHE ASN ALA ALA LYS VAL SEQRES 19 A 356 TYR ILE GLU ALA TYR HIS THR VAL PRO LYS GLY ARG CYS SEQRES 20 A 356 ARG GLN VAL VAL THR GLY MET ALA TRP LEU PHE PHE VAL SEQRES 21 A 356 SER TRP GLY MET PHE PRO ILE LEU PHE ILE LEU GLY PRO SEQRES 22 A 356 GLU GLY PHE GLY VAL LEU SER VAL TYR GLY SER THR VAL SEQRES 23 A 356 GLY HIS THR ILE ILE ASP LEU MET SER LYS ASN CYS TRP SEQRES 24 A 356 GLY LEU LEU GLY HIS TYR LEU ARG VAL LEU ILE HIS GLU SEQRES 25 A 356 HIS ILE LEU ILE HIS GLY ASP ILE ARG LYS THR THR LYS SEQRES 26 A 356 LEU ASN ILE GLY GLY THR GLU ILE GLU VAL GLU THR LEU SEQRES 27 A 356 VAL GLU ASP GLU ALA GLU ALA GLY ALA VAL SER SER GLU SEQRES 28 A 356 ASP LEU TYR PHE GLN HET NAG E 1 14 HET NAG E 2 14 HET RET A 401 20 HET OLC A 402 25 HET OLC A 403 16 HET OLC A 404 14 HET OLC A 405 16 HET OLC A 406 18 HET OLC A 407 10 HET OLC A 408 10 HET OLC A 409 9 HET OLC A 410 8 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM RET RETINAL HETNAM OLC (2R)-2,3-DIHYDROXYPROPYL (9Z)-OCTADEC-9-ENOATE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN OLC 1-OLEOYL-R-GLYCEROL FORMUL 2 NAG 2(C8 H15 N O6) FORMUL 3 RET C20 H28 O FORMUL 4 OLC 9(C21 H40 O4) FORMUL 13 HOH *38(H2 O) HELIX 1 AA1 LEU A 76 LYS A 80 5 5 HELIX 2 AA2 THR A 84 GLY A 110 1 27 HELIX 3 AA3 GLY A 119 GLU A 140 1 22 HELIX 4 AA4 VAL A 156 SER A 175 1 20 HELIX 5 AA5 ASN A 185 SER A 208 1 24 HELIX 6 AA6 LYS A 209 VAL A 242 1 34 HELIX 7 AA7 GLY A 245 GLY A 272 1 28 HELIX 8 AA8 SER A 280 LYS A 296 1 17 HELIX 9 AA9 LYS A 296 GLY A 318 1 23 SHEET 1 AA1 2 THR A 57 GLU A 59 0 SHEET 2 AA1 2 VAL A 64 CYS A 66 -1 O VAL A 64 N GLU A 59 SHEET 1 AA2 2 ILE A 147 TYR A 148 0 SHEET 2 AA2 2 LYS A 154 THR A 155 -1 O THR A 155 N ILE A 147 SHEET 1 AA3 3 ILE A 333 LEU A 338 0 SHEET 2 AA3 3 ARG A 321 ASN A 327 -1 N THR A 324 O VAL A 335 SHEET 3 AA3 3 ALA A 347 GLU A 351 1 O SER A 350 N LYS A 325 SSBOND 1 CYS A 66 CYS A 66 1555 3555 2.09 SSBOND 2 CYS A 73 CYS A 75 1555 3555 2.05 LINK ND2 ASN A 61 C1 NAG E 1 1555 1555 1.43 LINK NZ LYS A 296 C15 RET A 401 1555 1555 1.37 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.33 CISPEP 1 GLU A 143 PRO A 144 0 3.74 CRYST1 61.800 142.200 94.700 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016181 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007032 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010560 0.00000